| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/23/2008 | US7468426 Using lymphocytes expressing jun kinase as tools in detecting modulators for treatment of cell proliferative disorders |
| 12/23/2008 | US7468424 Antibody that binds to the protein; given amino acid sequence |
| 12/23/2008 | US7468268 Nucleic acid molecules encoding osteoclastogenesis inhibitory factor proteins |
| 12/23/2008 | US7468256 Tools for detecting Moraxella catarrhalis |
| 12/23/2008 | US7468254 Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 12/23/2008 | US7468184 Therapeutic agent for cachexia |
| 12/23/2008 | US7468183 using an isolated human antibody directed towards at least one oxidized fragment of apolipoprotein B; preparation of the antibody using a fragment library |
| 12/23/2008 | CA2580848C Technique for extracorporeal treatment of blood |
| 12/23/2008 | CA2344762C Tests for the rapid evaluation of ischemic states and kits |
| 12/23/2008 | CA2339791C Methods and compositions for cloning nucleic acid molecules |
| 12/23/2008 | CA2324115C A preventive or therapeutic agent for inflammatory bowel disease comprising il-6 antagonist as an active ingredient |
| 12/23/2008 | CA2267665C Bacillus thuringiensis cryet33 and cryet34 compositions and uses therefor |
| 12/23/2008 | CA2249320C Glycosylated humanized b-cell specific antibodies |
| 12/23/2008 | CA2212750C Humanized antibodies against cd3 |
| 12/23/2008 | CA2158822C Therapeutic agent for rheumatic disease |
| 12/18/2008 | WO2008154470A1 Nhibitor of the receptor activity of the s1p2 receptor for inhibiting pathological angiogenesis in the eye |
| 12/18/2008 | WO2008154439A1 Methods and compositions for inducing apoptosis in cancer cells |
| 12/18/2008 | WO2008154251A2 C3b antibodies and methods for the prevention and treatment of complement- associated disorders |
| 12/18/2008 | WO2008153967A1 Bk1 antagonist conjugates |
| 12/18/2008 | WO2008153722A1 Post-translational regulation of catalytic activities of cytochrome p450 46a1 and uses thereof |
| 12/18/2008 | WO2008153705A2 Methods of treating, diagnosing and detecting fgf21-associated disorders |
| 12/18/2008 | WO2008153692A2 Microrna expression profiling of cerebrospinal fluid |
| 12/18/2008 | WO2008153433A1 Monoclonal antibodies for detection of mullerian inhibiting substance and uses thereof |
| 12/18/2008 | WO2008153420A1 Methods of selecting host resistant animals |
| 12/18/2008 | WO2008153237A1 Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof |
| 12/18/2008 | WO2008153072A1 Gene sensitive to bone/joint disease and use thereof |
| 12/18/2008 | WO2008152816A1 Methods of identifying agents that modulate methylation of vegfr1 by smyd3 |
| 12/18/2008 | WO2008152447A2 Staphylococcus aureus specific anti-infectives |
| 12/18/2008 | WO2008152422A2 Binding proteins specific for insulin-like growth factors and uses thereof-909 |
| 12/18/2008 | WO2008151847A1 Autoantibody binding peptides and their use for the treatment of vascular diseases |
| 12/18/2008 | WO2008151819A2 Treatment of tumors using specific anti-l1 antibody |
| 12/18/2008 | WO2008151428A1 Novel compositions for modulating mrna translation |
| 12/18/2008 | WO2008151405A1 Expression of fusion proteins containing a single chain antibody fragment linked to elastin-like repeating units in transgenic plants |
| 12/18/2008 | WO2008131406A3 NEGATIVE IMMUNOMODULATION OF IMMUNE RESPONSES BY ERp5 |
| 12/18/2008 | WO2008131298A3 Prevention and treatment of cerebral amyloid angiopathy |
| 12/18/2008 | WO2008130969A3 Novel compounds |
| 12/18/2008 | WO2008125307B1 Ig-pCONSENSUS GENE VACCINATION PROTECTS FROM ANTIBODY-DEPENDENT IMMUNE PATHOLOGY IN AUTOIMMUNE DISEASE |
| 12/18/2008 | WO2008121385A3 Compositions and methods useful for modulating spondyloarthropathies |
| 12/18/2008 | WO2008118324A3 Composition and method of treating cancer with an anti-uroplakin ib antibody |
| 12/18/2008 | WO2008099071A3 Monoclonal antibody directed against the human ldl receptor |
| 12/18/2008 | WO2008096158A3 Antibody single variable domains against serum albumin |
| 12/18/2008 | WO2008094942A3 Humanized antibodies against cxcr3 |
| 12/18/2008 | WO2008094370A3 Method of detecting ocular diseases and pathologic conditions and treatment of same |
| 12/18/2008 | WO2008093246A3 Vegf receptor antagonist for treating organ transplant alloimmunity and arteriosclerosis |
| 12/18/2008 | WO2008091911A8 Use of antibody conjugates |
| 12/18/2008 | WO2008091535A3 Antibodies to phosphorylated-irak4 |
| 12/18/2008 | WO2008083174A3 Compositions and methods for the treatment of infections and tumors |
| 12/18/2008 | WO2008080153A3 A novel protein kinase c therapy for the treatment of acute lung injury |
| 12/18/2008 | WO2008076490A3 Histophilus somni antigens, compositions and methods of use |
| 12/18/2008 | WO2008073312B1 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof |
| 12/18/2008 | WO2008027236A3 Multispecific antibodies |
| 12/18/2008 | WO2007146857A8 Anti- mcp-1 antibodies expressed in lemna, compositions, methods and uses |
| 12/18/2008 | WO2007142667A3 Treatment of patients with autoantibody positive disease |
| 12/18/2008 | WO2007109742A3 Methods for humanizing antibodies and humanized antibodies made thereby |
| 12/18/2008 | WO2007098718A8 Chimeric vaccine antigens against the avian influenza virus |
| 12/18/2008 | WO2007089601A9 Nogo receptor antagonists |
| 12/18/2008 | US20080313749 Binding Compounds, Immunogenic Compounds and Peptidomimetics |
| 12/18/2008 | US20080312422 Processes for making hydrazides |
| 12/18/2008 | US20080312421 Use of A33 antigens and JAM-it |
| 12/18/2008 | US20080312420 Immunoglobulin for use in diagnosis of inflammatory diseases |
| 12/18/2008 | US20080312419 Confers resistance or tolerance to glyphosate herbicides; useful in plant biology, crop breeding, and plant cell culture |
| 12/18/2008 | US20080312418 Antibody Specific for Human 4-1BB Receptor |
| 12/18/2008 | US20080312417 Ucp5 |
| 12/18/2008 | US20080312410 Cysteine-containing peptide tag for site-specific conjugation of proteins |
| 12/18/2008 | US20080312178 Human G-Protein Receptor HGBER32 |
| 12/18/2008 | US20080312172 Anti-IL-6 Antibodies, Compositions, Methods and Uses |
| 12/18/2008 | US20080312158 Semaphorin Gene Family |
| 12/18/2008 | US20080311675 Dyes having ratiometric fluorescence response for detecting metabolites |
| 12/18/2008 | US20080311655 Heterodimeric fusion protein for use in the treatment of allergies and metastatic disease; cytokine linked to an antibody; nucleic acid encoding a fusion protein comprising an immunoglobulin (Ig) moiety linked by a peptide bond to the p35 subunit of interleukin-12 |
| 12/18/2008 | US20080311623 Plasmid system for multigene expression |
| 12/18/2008 | US20080311622 Activatable recombinant neurotoxins |
| 12/18/2008 | US20080311621 Polypeptides and nucleic acids encoding same |
| 12/18/2008 | US20080311608 Antagonist of the oncogenic activity of the protein MDM2, and use thereof in the treatment of cancers |
| 12/18/2008 | US20080311600 contacting a mammalian fecal preparation with polyclonal antibodies specific for Toxocara antigens and detecting the presence or absence of antigens or antibody/antigen complexes; medical diagnosis for infection by nematodes |
| 12/18/2008 | US20080311599 Antibodies against caspase-8, their preparation and use |
| 12/18/2008 | US20080311596 detecting the presence of an invasive Porphyromonas gingivalis infection in an animal; oral disorders |
| 12/18/2008 | US20080311588 nucleotide sequences coding transcription factor for use as regulatory tools in nervous system development; Protein/transcription factor in basic-helix-loop-helix (bHLH) gene family which plays role in cell determination; genetic engineering |
| 12/18/2008 | US20080311580 Novel genes encoding proteins involved in proanthocyanidin synthesis |
| 12/18/2008 | US20080311136 Triazole-Containing Releasable Linkers, Conjugates Thereof, and Methods of Preparation |
| 12/18/2008 | US20080311134 engineered by replacing one or more amino acids of a parent anti-MUC16 antibody with non cross-linked, reactive cysteine amino acids; Cys engineered anti-MUC16 antibodies (Ab) containing a heavy chain sequence, conjugated with one or more drug moieties through a linker; diagnostic and therapeutic uses |
| 12/18/2008 | US20080311133 Methods of using multivalent mhc class ii-peptide chimeras |
| 12/18/2008 | US20080311131 Human Mob-5 (IL-24) receptors and uses thereof |
| 12/18/2008 | US20080311127 Combination therapy for treating disease |
| 12/18/2008 | US20080311125 Scytovirin Domain 1 Related Polypeptides |
| 12/18/2008 | US20080311124 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 12/18/2008 | US20080311123 Compositions and methods for the therapy and diagnosis of breast cancer |
| 12/18/2008 | US20080311121 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 12/18/2008 | US20080311120 Autocrine growth factor receptor antibodies and methods |
| 12/18/2008 | US20080311118 Vascular endothelial cell growth factor antagonists and uses thereof |
| 12/18/2008 | US20080311117 Antibodies against PD-1 and uses therefor |
| 12/18/2008 | US20080311115 Atherosclerosis, rheumatoid arthritis (RA), psoriasis, psoriatic arthritis, bacteria-induced gastric ulcer, and acute renal failure |
| 12/18/2008 | US20080311111 Competitive Domain Antibody Formats That Bind Interleukin 1 Receptor Type 1 |
| 12/18/2008 | US20080311110 Chimeric Vaccine for Haemophilus Influenzae-Induced Disease |
| 12/18/2008 | US20080311109 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 12/18/2008 | US20080311108 Polypeptides |
| 12/18/2008 | US20080311107 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 12/18/2008 | US20080311034 Anti-Tissue Factor Antibodies and Compositions with Enhanced Effector Function |
| 12/18/2008 | US20080309895 Dynamic fluid control system for immersion lithography |
| 12/18/2008 | CA2691159A1 Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof |
| 12/18/2008 | CA2691075A1 Treatment of tumors using specific anti-l1 antibody |